2006-10-012024-05-14https://scholars.lib.ntu.edu.tw/handle/123456789/661553摘要：行內容(中文摘要)： 自1962年首次合成那利得酸後，奎諾酮或氟奎諾酮類藥物即被大量合成與廣泛使 用，但基於抗藥性細菌的產生，禽畜水產品殘留與公共衛生的考量等相繼發生與 被重視，本類藥物的使用，已有相當的規範。烏骨雞為傳統重要蛋白質來源之ㄧ ，但由於其生長期長，基於治療需要，故常見藥物殘留。本研究的目的，在於了 解於烏骨雞口服投與恩氟奎寧羧酸後，血液與肌肉中的殘留特性，相關資料亦可 協助類似藥品停藥期之評估，以提升禽畜水產品之安全，提升消費者的信心。 <br> Abstract: Since nalidixic acid was first synthesized in 1962, the quinolone/fluoroquinolone compounds has been made and used extensively. However, the bacterial resistance, residue within edible tissues and public health concerns also is rose by consumers. Silky fowl is a valuable protein source. However, the growth period for silk fowl is much longer than regular poultry. For therapeutic and disease control reasons, enrofloxacin become one of the easiest residue drug in silky fowl. The purpose of this study is to define the tissues residue characteristics of enrofloxacin at silky fowl. These results also can be used to evaluate withdrew periods of related compounds and enhance the consumption of silky fowl.恩氟奎寧羧酸烏骨雞殘留Enrofloxacinsilky fowlresidue